As China rushes in with its COVID-19 shots, India is now in a race with China in making a locally-produced coronavirus vaccine accessible to the entire South Asian region, reports The Pharma Letter’s local correspondent.
Months after its successful campaign to supply hydroxychloroquine (HCQ) around the world, India is looking at a COVID-19 vaccine diplomacy with its neighbors, even as China is offering its own Sinovac Biotech-made vaccine to Pakistan, Sri Lanka, Nepal and Bangladesh.
India's Ministry of External Affairs has already instructed India’s ambassadors and high commissioners in the neighboring nations to assess the need for vaccines in their respective areas.
During his recent trips to the neighboring countries, Foreign Secretary Harsh V Shringla committed COVID-19 vaccines to Nepal, Bangladesh and Myanmar as part of Prime Minister Narendra Modi’s coronavirus cooperation initiative.
PM Modi has suggested developing a vaccine delivery system that is on the lines of how elections are conducted in the country and disaster management work is conducted.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze